Mesenchymal stem cell therapy for attenuation of scar formation during wound healing

Stem Cell Research and Therapy

Volumn 3, Issue 3, 2012, Pages

  Jackson, Wesley M ^a,b   Nesti, Leon J ^a,c   Tuan, Rocky S ^d  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; INTERLEUKIN 10; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR;

ANGIOGENESIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; HUMAN; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SCAR FORMATION; TISSUE REGENERATION; WOUND HEALING; ANIMAL; CELL PROLIFERATION; CYTOLOGY; MACROPHAGE ACTIVATION; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY; REVIEW; SCAR; SKIN;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CICATRIX; HEPATOCYTE GROWTH FACTOR; HUMANS; MACROPHAGE ACTIVATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; REACTIVE OXYGEN SPECIES; SKIN; WOUND HEALING;

EID: 84861830404     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt111     Document Type: Article

References (121)

1. Wound healing-aiming for perfect skin regeneration. Martin P, Science 1997 276 75 81 10.1126/science.276.5309.75 9082989 (Pubitemid 27161246)
2. Wound repair overview and general considerations. Clark R, The Molecular and Cellular Biology of Wound Repair Plenum Press, Clark R, 1996 3 50
3. Fetal skin wound healing. Buchanan EP, Longaker MT, Lorenz HP, Adv Clin Chem 2009 48 137 161 19803418
4. The wound healing process: an overview of the cellular and molecular mechanisms. Velnar T, Bailey T, Smrkolj V, J Int Med Res 2009 37 1528 1542 19930861
5. Novel therapies for scar reduction and regenerative healing of skin wounds. Rhett JM, Ghatnekar GS, Palatinus JA, O'Quinn M, Yost MJ, Gourdie RG, Trends Biotechnol 2008 26 173 180 10.1016/j.tibtech.2007.12.007 18295916
6. Participation of bone marrow derived cells in cutaneous wound healing. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P, J Cell Physiol 2003 196 245 250 10.1002/jcp.10260 12811816 (Pubitemid 36775870)
7. Mesenchymal stromal cells: current understanding and clinical status. Salem HK, Thiemermann C, Stem Cells 2010 28 585 596 19967788
8. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606 (Pubitemid 44269669)
9. Mesenchymal stem cells as trophic mediators. Caplan AI, Dennis JE, J Cell Biochem 2006 98 1076 1084 10.1002/jcb.20886 16619257 (Pubitemid 44128350)
10. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, Ruadkow IA, Exp Hematol 1974 2 83 92 4455512
11. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Gimble JM, Guilak F, Cytotherapy 2003 5 362 369 10.1080/14653240310003026 14578098 (Pubitemid 37369023)
12. Adipose-derived cells. Meliga E, Strem BM, Duckers HJ, Serruys PW, Cell Transplant 2007 16 963 970 10.3727/096368907783338190 18293895 (Pubitemid 351448614)
13. Current state of cartilage tissue engineering. Tuli R, Li WJ, Tuan RS, Arthritis Res Ther 2003 5 235 238 10.1186/ar991 12932283 (Pubitemid 37139038)
14. Tissue engineering with mesenchymal stem cells. Kuo CK, Tuan RS, IEEE Eng Med Biol Mag 2003 22 51 56 10.1109/MEMB.2003.1256272 (Pubitemid 38005031)
15. Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Song L, Young NJ, Webb NE, Tuan RS, Stem Cells Dev 2005 14 712 721 10.1089/scd.2005.14.712 16433626 (Pubitemid 43201905)
16. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Tuli R, Tuli S, Nandi S, Wang ML, Alexander PG, Haleem-Smith H, Hozack WJ, Manner PA, Danielson KG, Tuan RS, Stem Cells 2003 21 681 693 10.1634/stemcells.21-6-681 14595128 (Pubitemid 37329161)
17. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. Noth U, Osyczka A, Tuli R, Hickok N, Danielson K, Tuan R, J Orthop Res 2002 20 1060 1069 10.1016/S0736-0266(02)00018-9 12382974
18. In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Nakahara H, Dennis JE, Bruder SP, Haynesworth SE, Lennon DP, Caplan AI, Exp Cell Res 1991 195 492 503 10.1016/0014-4827(91)90401-F 2070830 (Pubitemid 121006351)
19. Multipotency and growth characteristic of periosteum-derived progenitor cells for chondrogenic, osteogenic, and adipogenic differentiation. Choi Y-S, Noh S-E, Lim S-M, Lee C-W, Kim C-S, Im M-W, Lee M-H, Kim D-I, Biotechnol Lett 2008 30 593 601 10.1007/s10529-007-9584-2 17985079
20. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, McGonagle D, Arthritis Rheum 2004 50 817 827 10.1002/art.20203 15022324 (Pubitemid 38326182)
21. Morphological and immunocytochemical characterization of cultured fibroblast-like cells derived from adult human synovial membrane. Vandenabeele F, De Bari C, Moreels M, Lambrichts I, Dell'Accio F, Lippens PL, Luyten FP, Arch Histol Cytol 2003 66 145 153 10.1679/aohc.66.145 12846554 (Pubitemid 36834423)
22. Synovium-derived mesenchymal stem cells: A new cell source for musculoskeletal regeneration. Fan J, Varshney RR, Ren L, Cai D, Wang D-A, Tissue Eng Part B Rev 2009 15 75 86 19196118
23. Isolation and characterization of postnatal stem cells from human dental tissues. Jo YY, Lee HJ, Kook SY, Choung HW, Park JY, Chung JH, Choung YH, Kim ES, Yang HC, Choung PH, Tissue Eng 2007 13 767 773 10.1089/ten.2006.0192 17432951 (Pubitemid 46651507)
24. Isolation and characterization of multipotent human periodontal ligament stem cells. Gay IC, Chen S, MacDougall M, Orthod Craniofac Res 2007 10 149 160 10.1111/j.1601-6343.2007.00399.x 17651131
25. Human palatine tonsil: a new potential tissue source of multipotent mesenchymal progenitor cells. Janjanin S, Djouad F, Shanti RM, Baksh D, Gollapudi K, Prgomet D, Rackwitz L, Joshi AS, Tuan RS, Arthritis Res Ther 2008 10 83 10.1186/ar2459 18662393
26. Isolation and characterization of stem cells from the human parathyroid gland. Shih YR, Kuo TK, Yang AH, Lee OK, Lee CH, Cell Prolif 2009 42 461 470 10.1111/j.1365-2184.2009.00614.x 19489980
27. Human fallopian tube: a new source of multipotent adult mesenchymal stem cells discarded in surgical procedures. Jazedje T, Perin PM, Czeresnia CE, Maluf M, Halpern S, Secco M, Bueno DF, Vieira NM, Zucconi E, Zatz M, J Transl Med 2009 7 46 10.1186/1479-5876-7-46 19538712
28. Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. Nesti LJ, Jackson WM, Shanti RM, Koehler SM, Aragon AB, Bailey JR, Sracic MK, Freedman BA, Giuliani JR, Tuan RS, J Bone Joint Surg Am 2008 90 2390 2398 10.2106/JBJS.H.00049 18978407
29. Mesenchymal progenitor cells derived from traumatized human muscle. Jackson WM, Aragon AB, Djouad F, Song Y, Koehler SM, Nesti LJ, Tuan RS, J Tissue Eng Regen Med 2009 3 129 138 10.1002/term.149 19170141
30. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Baksh D, Yao R, Tuan RS, Stem Cells 2007 25 1384 1392 10.1634/stemcells.2006-0709 17332507 (Pubitemid 47106005)
31. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Lee OK, Kuo TK, Chen W-M, Lee K-D, Hsieh S-L, Chen T-H, Blood 2004 103 1669 1675 10.1182/blood-2003-05-1670 14576065 (Pubitemid 38268958)
32. Cord-blood mesenchymal stem cells and tissue engineering. Cetrulo CL Jr, Stem Cell Rev 2006 2 163 168 10.1007/s12015-006-0023-x 17237555 (Pubitemid 46137577)
33. Concise Review: Wharton's jelly-derived cells are a primitive stromal cell population. Troyer DL, Weiss ML, Stem Cells 2008 26 591 599 10.1634/stemcells.2007-0439 18065397
34. The hidden treasure in apical papilla: The potential role in pulp/dentin regeneration and BioRoot engineering. Huang GT, Sonoyama W, Liu Y, Liu H, Wang S, Shi S, J Endod 2008 34 645 651 10.1016/j.joen.2008.03.001 18498881
35. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. Huang GT, Gronthos S, Shi S, J Dent Res 2009 88 792 806 10.1177/0022034509340867 19767575
36. All MSCs are pericytes? Caplan AI, Cell Stem Cell 2008 3 229 230 10.1016/j.stem.2008.08.008 18786406
37. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA, Cytotherapy 2009 11 377 391 10.1080/14653240903080367 19568970
38. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, Charbord P, Domenech J, Stem Cells 2007 25 1737 1745 10.1634/stemcells.2007-0054 17395768 (Pubitemid 47121852)
39. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H, J Immunol 2008 180 2581 2587 18250469
40. Chemotaxis of human articular chondrocytes and mesenchymal stem cells. Mishima Y, Lotz M, J Orthop Res 2008 26 1407 1412 10.1002/jor.20668 18464249
41. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, Brandau S, Stem Cells Dev 2010 19 693 706 10.1089/scd.2009.0365 20067407
42. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG, Proc Natl Acad Sci USA 2003 100 8407 8411 10.1073/pnas.1432929100 12815096 (Pubitemid 36842558)
43. Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. Chen L, Tredget EE, Liu C, Wu Y, PLoS One 2009 4 7119 10.1371/journal.pone.0007119 19771171
44. Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue. Deng W, Han Q, Liao L, Li C, Ge W, Zhao Z, You S, Deng H, Murad F, Zhao RC, Tissue Eng 2005 11 110 119 10.1089/ten.2005.11.110 15738666 (Pubitemid 40515179)
45. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Ishii G, Sangai T, Sugiyama K, Ito T, Hasebe T, Endoh Y, Magae J, Ochiai A, Stem Cells 2005 23 699 706 10.1634/stemcells.2004-0183 15849177 (Pubitemid 40647266)
46. Impact of enhanced mobilization of bone marrow derived cells to site of injury. Hannoush EJ, Sifri ZC, Elhassan IO, Mohr AM, Alzate WD, Offin M, Livingston DH, J Trauma 2011 71 283 289 10.1097/TA.0b013e318222f380 21825928
47. Immune modulation by mesenchymal stem cells. Rasmusson I, Exp Cell Res 2006 312 2169 2179 10.1016/j.yexcr.2006.03.019 16631737 (Pubitemid 43928946)
48. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Djouad F, Bouffi C, Ghannam S, Noel D, Jorgensen C, Nat Rev Rheumatol 2009 5 392 399 10.1038/nrrheum.2009.104 19568253
49. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y, Cell Stem Cell 2008 2 141 150 10.1016/j.stem.2007. 11.014 18371435 (Pubitemid 351181031)
50. Concise review: Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Chamberlain G, Fox J, Ashton B, Middleton J, Stem Cells 2007 25 2739 2749 10.1634/stemcells.2007- 0197 17656645 (Pubitemid 350127858)
51. Human mesenchymal stem cells modulate B-cell functions. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi G, Pistoia V, Uccelli A, Blood 2006 107 367 372 10.1182/blood-2005-07- 2657 16141348 (Pubitemid 43053565)
52. Interactions between human mesenchymal stem cells and natural killer cells. Sotiropoulou P, Perez S, Gritzapis A, Baxevanis C, Papamichail M, Stem Cells 2006 24 74 85 10.1634/stemcells.2004-0359 16099998
53. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB, Nat Cell Biol 1999 1 260 266 10.1038/12971 10559937 (Pubitemid 129495775)
54. Wound healing and inflammation: embryos reveal the way to perfect repair. Redd MJ, Cooper L, Wood W, Stramer B, Martin P, Philos Trans R Soc Lond B Biol Sci 2004 359 777 784 10.1098/rstb.2004.1466 15293805 (Pubitemid 38673745)
55. Alternative activation of macrophages: an immunologic functional perspective. Martinez FO, Helming L, Gordon S, Annu Rev Immunol 2009 27 451 483 10.1146/annurev.immunol.021908.132532 19105661
56. Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo. Trautmann A, Toksoy A, Engelhardt E, Brocker EB, Gillitzer R, J Pathol 2000 190 100 106 10.1002/(SICI)1096- 9896(200001)190:1<100::AID-PATH496>3.0.CO;2-Q 10640999 (Pubitemid 30053360)
57. Editorial: macrophage functional phenotypes: no alternatives in dermal wound healing? Stout RD, J Leukoc Biol 2010 87 19 21 10.1189/jlb.0509311 20047887
58. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, Klagsbrun M, Proc Natl Acad Sci USA 1993 90 3889 3893 10.1073/pnas.90.9.3889 8483908 (Pubitemid 23134131)
59. Growth factors and cytokines in wound healing. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M, Wound Repair Regen 2008 16 585 601 10.1111/j.1524-475X.2008.00410.x 19128254
60. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E, Nat Med 2009 15 42 49 10.1038/nm.1905 19098906
61. Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. Jarvinen L, Badri L, Wettlaufer S, Ohtsuka T, Standiford TJ, Toews GB, Pinsky DJ, Peters-Golden M, Lama VN, J Immunol 2008 181 4389 4396 18768898
62. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, Apparailly F, Cantos C, Jorgensen C, Noel D, Stem Cells 2007 25 2025 2032 10.1634/stemcells.2006-0548 17510220 (Pubitemid 47258180)
63. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes. Zanone MM, Favaro E, Miceli I, Grassi G, Camussi E, Caorsi C, Amoroso A, Giovarelli M, Perin PC, Camussi G, J Clin Endocrinol Metab 2010 95 3788 3797 10.1210/jc.2009-2350 20466784
64. Human mesenchymal stem cells modulate allogeneic immune cell responses. Aggarwal S, Pittenger M, Blood 2005 105 1815 1822 10.1182/blood-2004-04-1559 15494428 (Pubitemid 40223708)
65. Alternative activation of macrophages: immune function and cellular biology. Varin A, Gordon S, Immunobiology 2009 214 630 641 10.1016/j.imbio.2008. 11.009 19264378
66. Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Benbernou N, Esnault S, Shin HC, Fekkar H, Guenounou M, Immunology 1997 91 361 368 10.1046/j.1365-2567.1997.00260.x 9301524 (Pubitemid 27304271)
67. Interleukin-10 and the interleukin-10 receptor. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A, Annu Rev Immunol 2001 19 683 765 10.1146/annurev. immunol.19.1.683 11244051 (Pubitemid 32368050)
68. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Sato Y, Ohshima T, Kondo T, Biochem Biophys Res Commun 1999 265 194 199 10.1006/bbrc.1999.1455 10548513
69. Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. Reitamo S, Remitz A, Tamai K, Uitto J, J Clin Invest 1994 94 2489 2492 10.1172/JCI117618 7989607 (Pubitemid 24379626)
70. Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. Liechty KW, Kim HB, Adzick NS, Crombleholme TM, J Pediatr Surg 2000 35 866 872 10.1053/jpsu.2000.6868 10873028
71. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, Zoltick PW, Liechty KW, J Invest Dermatol 2008 128 1852 1860 10.1038/sj.jid.5701232 18200061 (Pubitemid 351847365)
72. Permissive environment in postnatal wounds induced by adenoviral-mediated overexpression of the anti-inflammatory cytokine interleukin-10 prevents scar formation. Gordon A, Kozin ED, Keswani SG, Vaikunth SS, Katz AB, Zoltick PW, Favata M, Radu AP, Soslowsky LJ, Herlyn M, Crombleholme TM, Wound Repair Regen 2008 16 70 79 10.1111/j.1524-475X.2007.00326.x 18086289
73. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K, Ozawa K, Blood 2007 109 228 234 10.1182/blood-2006-02-002246 16985180 (Pubitemid 46053063)
74. Pathogenesis of liver fibrosis: role of oxidative stress. Poli G, Mol Aspects Med 2000 21 49 98 10.1016/S0098-2997(00)00004-2 10978499 (Pubitemid 30642764)
75. Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Muriel P, Biochem Pharmacol 1998 56 773 779 10.1016/S0006-2952(98)00220-2 9751083 (Pubitemid 28454589)
76. Antioxidant effects of nitric oxide. Wink DA, Vodovotz Y, Grisham MB, DeGraff W, Cook JC, Pacelli R, Krishna M, Mitchell JB, Methods Enzymol 1999 301 413 424 9919590 (Pubitemid 28489803)
77. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Beckman JS, Koppenol WH, Am J Physiol 1996 271 1424 1437 8944624
78. Antifibrotic role of inducible nitric oxide synthase. Ferrini MG, Vernet D, Magee TR, Shahed A, Qian A, Rajfer J, Gonzalez-Cadavid NF, Nitric Oxide 2002 6 283 294 10.1006/niox.2001.0421 12009846 (Pubitemid 34852372)
79. Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Li L, Zhang Y, Li Y, Yu B, Xu Y, Zhao S, Guan Z, Transpl Int 2008 21 1181 1189 10.1111/j.1432-2277. 2008.00742.x 18783386
80. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. Chen L, Tredget EE, Wu PY, Wu Y, PLoS One 2008 3 1886 10.1371/journal.pone.0001886 18382669 (Pubitemid 351943822)
81. Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Li L, Zhang S, Zhang Y, Yu B, Xu Y, Guan Z, Mol Biol Rep 2009 36 725 731 10.1007/s11033-008- 9235-2 18368514
82. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts. Mou S, Wang Q, Shi B, Gu L, Ni Z, Kaohsiung J Med Sci 2009 25 577 587 10.1016/S1607-551X(09)70560-1 19858036
83. Profiling of anti-fibrotic signaling by hepatocyte growth factor in renal fibroblasts. Schievenbusch S, Strack I, Scheffler M, Wennhold K, Maurer J, Nischt R, Dienes HP, Odenthal M, Biochem Biophys Res Commun 2009 385 55 61 10.1016/j.bbrc.2009.05.010 19426716
84. Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7. Inagaki Y, Higashi K, Kushida M, Hong YY, Nakao S, Higashiyama R, Moro T, Itoh J, Mikami T, Kimura T, Shiota G, Kuwabara I, Okazaki I, Gastroenterology 2008 134 1180 1190 10.1053/j.gastro. 2008.01.014 18395096 (Pubitemid 351451969)
85. Hepatocyte growth factor gene transfer with naked plasmid DNA ameliorates dimethylnitrosamine-induced liver fibrosis in rats. Kanemura H, Iimuro Y, Takeuchi M, Ueki T, Hirano T, Horiguchi K, Asano Y, Fujimoto J, Hepatol Res 2008 38 930 939 10.1111/j.1872-034X.2008.00340.x 18637143
86. Diverse and potent activities of HGF/SF in skin wound repair. Bevan D, Gherardi E, Fan TP, Edwards D, Warn R, J Pathol 2004 203 831 838 10.1002/path.1578 15221943 (Pubitemid 38961570)
87. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. Gille J, Khalik M, Konig V, Kaufmann R, J Invest Dermatol 1998 111 1160 1165 10.1046/j.1523-1747.1998.00418.x 9856833 (Pubitemid 29115191)
88. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Estes JM, Vande Berg JS, Adzick NS, MacGillivray TE, Desmouliere A, Gabbiani G, Differentiation 1994 56 173 181 10.1046/j.1432-0436.1994.5630173.x 8034132 (Pubitemid 24148224)
89. Phenotypic differences between oral and skin fibroblasts in wound contraction and growth factor expression. Shannon DB, McKeown ST, Lundy FT, Irwin CR, Wound Repair Regen 2006 14 172 178 10.1111/j.1743-6109.2006.00107.x 16630106
90. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Shukla MN, Rose JL, Ray R, Lathrop KL, Ray A, Ray P, Am J Respir Cell Mol Biol 2009 40 643 653 10.1165/rcmb.2008-0217OC 18988920
91. Fibroblasts and myofibroblasts: their source, function and role in disease. McAnulty RJ, Int J Biochem Cell Biol 2007 39 666 671 10.1016/j.biocel.2006.11.005 17196874 (Pubitemid 46366802)
92. Fibroblast differentiation of bone marrow-derived cells during wound repair. Opalenik SR, Davidson JM, Faseb J 2005 19 1561 1563 16014399 (Pubitemid 41279031)
93. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN, J Immunol 2001 166 7556 7562 11390511 (Pubitemid 32525636)
94. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A, Mol Med 1994 1 71 81 8790603
95. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. Yang J, Dai C, Liu Y, J Am Soc Nephrol 2005 16 68 78 15537870 (Pubitemid 43073158)
96. Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor. Zhang A, Wang MH, Dong Z, Yang T, Am J Physiol Renal Physiol 2006 291 1323 1331 10.1152/ajprenal.00480. 2005 16868306 (Pubitemid 44887246)
97. Mesenchymal stem cells induce dermal fibroblast responses to injury. Smith AN, Willis E, Chan VT, Muffley LA, Isik FF, Gibran NS, Hocking AM, Exp Cell Res 2010 316 48 54 10.1016/j.yexcr.2009.08.001 19666021
98. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L, J Exp Med 1992 176 1375 1379 10.1084/jem.176.5.1375 1402682
99. Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Gruber R, Kandler B, Holzmann P, Vogele-Kadletz M, Losert U, Fischer MB, Watzek G, Tissue Eng 2005 11 896 903 10.1089/ten.2005.11.896 15998229 (Pubitemid 40960792)
100. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Kaigler D, Krebsbach PH, Polverini PJ, Mooney DJ, Tissue Eng 2003 9 95 103 10.1089/107632703762687573 12625958 (Pubitemid 36228181)
101. Mesenchymal stem cell modification of endothelial matrix regulates their vascular differentiation. Lozito TP, Taboas JM, Kuo CK, Tuan RS, J Cell Biochem 2009 107 706 713 10.1002/jcb.22166 19415686
102. Adrenomedullin: a protective factor for blood vessels. Kato J, Tsuruda T, Kita T, Kitamura K, Eto T, Arterioscler Thromb Vasc Biol 2005 25 2480 2487 10.1161/01.ATV.0000184759.91369.f8 16141406 (Pubitemid 43732267)
103. The Hedgehog transcription factor Gli3 modulates angiogenesis. Renault MA, Roncalli J, Tongers J, Misener S, Thorne T, Jujo K, Ito A, Clarke T, Fung C, Millay M, Kamide C, Scarpelli A, Klyachko E, Losordo DW, Circ Res 2009 105 818 826 10.1161/CIRCRESAHA.109.206706 19729595
104. Mesenchymal stem cells: revisiting history, concepts, and assays. Bianco P, Robey P, Simmons P, Cell Stem Cell 2008 2 313 319 10.1016/j.stem.2008.03.002 18397751 (Pubitemid 351467394)
105. Influence of adult mesenchymal stem cells on in vitro vascular formation. Sorrell JM, Baber MA, Caplan AI, Tissue Eng Part A 2009 15 1751 1761 10.1089/ten.tea.2008.0254 19196139
106. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Au P, Tam J, Fukumura D, Jain RK, Blood 2008 111 4551 4558 10.1182/blood-2007-10-118273 18256324
107. Bone marrow cells differentiate into wound myofibroblasts and accelerate the healing of wounds with exposed bones when combined with an occlusive dressing. Yamaguchi Y, Kubo T, Murakami T, Takahashi M, Hakamata Y, Kobayashi E, Yoshida S, Hosokawa K, Yoshikawa K, Itami S, Br J Dermatol 2005 152 616 622 10.1111/j.1365-2133.2005.06402.x 15840089 (Pubitemid 40571290)
108. Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury. Fu X, Fang L, Li X, Cheng B, Sheng Z, Wound Repair Regen 2006 14 325 335 10.1111/j.1743-6109.2006.00128.x 16808812 (Pubitemid 43979263)
109. Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. Lozito TP, Kuo CK, Taboas JM, Tuan RS, J Cell Biochem 2009 107 714 722 10.1002/jcb.22167 19415687
110. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Wu Y, Chen L, Scott PG, Tredget EE, Stem Cells 2007 25 2648 2659 10.1634/stemcells.2007-0226 17615264 (Pubitemid 47582758)
111. New concepts on the immune modulation mediated by mesenchymal stem cells. Bunnell BA, Betancourt AM, Sullivan DE, Stem Cell Res Ther 2010 1 34 10.1186/scrt34 21092149
112. Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Raicevic G, Rouas R, Najar M, Stordeur P, Boufker HI, Bron D, Martiat P, Goldman M, Nevessignsky MT, Lagneaux L, Hum Immunol 2010 71 235 244 10.1016/j.humimm.2009.12.005 20034529
113. Clinical translation of wound healing therapies based on mesenchymal stem cells. Jackson WM, Nesti LJ, Tuan RS, Stem Cells Trans Med 2012
114. ClinicalTrials.gov. http://www.clinicaltrials.gov
115. Topical delivery of mesenchymal stem cells and their function in wounds. Sorrell JM, Caplan AI, Stem Cell Res Ther 2010 1 30 10.1186/scrt30 20863417
116. Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Javazon EH, Keswani SG, Badillo AT, Crombleholme TM, Zoltick PW, Radu AP, Kozin ED, Beggs K, Malik AA, Flake AW, Wound Repair Regen 2007 15 350 359 10.1111/j.1524-475X.2007.00237.x 17537122 (Pubitemid 46817411)
117. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Nie C, Yang D, Xu J, Si Z, Jin X, Zhang J, Cell Transplant 2010 20 205 216 20719083
118. Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Stoff A, Rivera AA, Sanjib Banerjee N, Moore ST, Michael Numnum T, Espinosa-de-Los-Monteros A, Richter DF, Siegal GP, Chow LT, Feldman D, Vasconez LO, Michael Mathis J, Stoff-Khalili MA, Curiel DT, Exp Dermatol 2009 18 362 369 10.1111/j.1600-0625.2008.00792.x 18803656
119. Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. Egana JT, Fierro FA, Kruger S, Bornhauser M, Huss R, Lavandero S, Machens HG, Tissue Eng Part A 2009 15 1191 1200 10.1089/ten.tea.2008.0097 18925832
120. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, Shrayer D, Carson P, Tissue Eng 2007 13 1299 1312 10.1089/ten.2006.0278 17518741 (Pubitemid 46986730)
121. Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. McFarlin K, Gao X, Liu YB, Dulchavsky DS, Kwon D, Arbab AS, Bansal M, Li Y, Chopp M, Dulchavsky SA, Gautam SC, Wound Repair Regen 2006 14 471 478 10.1111/j.1743-6109.2006.00153.x 16939576 (Pubitemid 44266605)